| Product Name | MF | CAS | Details |
|---|
| Bcl-2-IN-16 | 2858632-01-4 | Details |
| Hydroxydione | C21H32O3 | 303-01-5 | Details |
| DosatiLink-2 | 2941512-38-3 | Details |
| Antitumor agent-29 | 2847856-44-2 | Details |
| CDFI | 1199797-92-6 | Details |
| APS3 | 1225373-70-5 | Details |
| Gly-Mal-Gly-Gly-Phe-Gly-amide-methylcyclopropane-Exatecan | 2766786-76-7 | Details |
| HDAC6-IN-21 | 2920929-76-4 | Details |
| Anticancer agent 162 | 2761736-66-5 | Details |
| ASC-69 | C19H19N7 | 1216665-50-7 | Details |
| Antitumor agent-120 | C17H16N2O3 | 948901-10-8 | Details |
| Fmoc-VAP-MMAE | C70H98N8O13 | 1912408-91-3 | Details |
| Elastase LasB-IN-1 | 2762675-17-0 | Details |
| CCG-232964 | C15H15ClN2O3S | 2349373-70-0 | Details |
| Anticancer agent 131 | 2864443-47-8 | Details |
| Epigenetic factor-IN-1 | C32H34FN5O6S2 | 2640673-56-7 | Details |
| DL-01 | C55H71N9O13S | 2821770-49-2 | Details |
| Antitumor agent-40 | C30H54NaO77PS16 | 2096500-09-1 | Details |
| AP-C3 | 682795-78-4 | Details |
| BCR-ABL-IN-8 | 1808288-49-4 | Details |
| Anticancer agent 86 | 2841406-04-8 | Details |
| Human enteropeptidase-IN-3 | 1958037-36-9 | Details |
| GSPT1 degrader-2 | C22H20ClN3O5 | 2803879-60-7 | Details |
| Anticancer agent 95 | C30H32ClN5O3 | 853302-91-7 | Details |
| Antitumor photosensitizer-2 | C40H47N5O7 | 2344751-92-2 | Details |
| AP-C1 | 2234280-26-1 | Details |
| Antiproliferative agent-37 | C21H17FN2O2 | 2989275-31-0 | Details |
| AP-C7 | 2234275-84-2 | Details |
| Elisidepsin | C75H124N14O16 | 681272-30-0 | Details |
| Antitumor photosensitizer-1 | 2344751-89-7 | Details |
| Dual photoCORM 1 | 2892235-55-9 | Details |
| IA1-8H2 | 2755685-19-7 | Details |
| HCoV-OC43-IN-1 | 2809363-81-1 | Details |
| DosatiLink-1 | 2941512-37-2 | Details |
| CL2E-SN38 | C87H116N14O24 | 1639139-65-3 | Details |
| Glucocorticoid receptor agonist-1 phosphate Gly-Glu TFA | 2734877-83-7 | Details |
| AtPCO4-IN-1 | C24H30O6 | 316134-38-0 | Details |
| Estrogen receptor modulator 10 | 2991504-90-4 | Details |
| GPR139 agonist-2 | 2983118-29-0 | Details |
| DYSP-C34 | C45H47N5O10 | 2559734-98-2 | Details |
| HCAR2 agonist 1 | C26H28N4O2 | 1066676-21-8 | Details |
| BChE-IN-20 | 1428439-79-5 | Details |
| Antifungal agent 77 | 2863678-89-9 | Details |
| Biotin-hexanamide-(L-Thyroxine) | 2278192-78-0 | Details |
| DDO-2213 | 2378768-36-4 | Details |
| Fluorescein octadecyl ester | C38H48O5 | 138833-46-2 | Details |
| ATAC21 | 2101204-23-1 | Details |
| Cy-FBP/SBPase-IN-1 | C18H14Cl2N4O2S3 | 444792-16-9 | Details |
| Antitumor agent-67 | 2820146-10-7 | Details |
| ICMT-IN-1 | 1313603-22-3 | Details |
| HDAC1/CDK7-IN-1 | 2987905-95-1 | Details |
| BX-2819 | 1184181-50-7 | Details |
| Dibutepinephrine | C17H25NO5 | 2735735-23-4 | Details |
| Bcl-2-IN-12 | 1383737-59-4 | Details |
| FGFR3-IN-6 | 2833703-72-1 | Details |
| Free radical scavenger 1 | 2989970-81-0 | Details |
| Antiproliferative agent-39 | C22H22N4O3 | 871837-61-5 | Details |
| Cholesterol 24-hydroxylase-IN-2 | C20H23FN4O | 1613481-52-9 | Details |
| CcpA-IN-1 | 2702277-62-9 | Details |
| Anti-MI/R injury agent 1 | C32H49NO6 | 2387506-35-4 | Details |
| Anticancer agent 168 | C16H11ClN2O6 | 207399-56-2 | Details |
| GEM–IB | 2866211-93-8 | Details |
| AP-C6 | C15H15N5O | 2234276-60-7 | Details |
| CD33 splicing modulator 1 hydrochloride | C25H25FN6O.ClH | 2762547-06-6 | Details |
| Bemfivastatin hemicalcium | C34 H37 F N2 O6 . 1/2 Ca | 805241-64-9 | Details |
| D359-0396 | C24H24N4O2 | 1031977-31-7 | Details |
| DQP-997-74 | 2377187-09-0 | Details |
| Antitumor agent-49 | 2763914-21-0 | Details |
| CU06-1004 | 1296734-08-1 | Details |
| ATUX-1215 | 2910929-53-0 | Details |
| FPR2 agonist 3 | 2829263-19-4 | Details |
| Antiproliferative agent-38 | C15H10N2 | 239-13-4 | Details |
| D1N8 | 2894770-40-0 | Details |
| FAAH/cPLA2α-IN-1 | 1696401-38-3 | Details |
| cis-Indatraline hydrochloride | C16H15Cl2N.ClH | 86939-08-4 | Details |
| Civorebrutinib | C23H22ClN7O2 | 2155853-43-1 | Details |
| Anti-hepatic fibrosis agent 2 | 2380421-60-1 | Details |
| Bcl-2-IN-13 | 1421687-31-1 | Details |
| Anticancer agent 166 | C19H14OS | 6630-80-4 | Details |
| Antiproliferative agent-40 | C20H18N4O3 | 871837-59-1 | Details |
| FGFR3-IN-7 | 2833703-79-8 | Details |
| FOXM1-IN-2 | 2694866-10-7 | Details |
| GPR3 agonist-2 | 1983120-51-9 | Details |
| Cyclohexyl [3,5-bis(methylthio)-4-isothiazolyl]carbamate | 311334-13-1 | Details |
| Anticancer agent 112 | C27H32ClN7O | 2495321-37-2 | Details |
| E104 | 1610431-21-4 | Details |
| GABA-IN-2 | 2363715-13-1 | Details |
| GGFG-Eribulin | 2841688-66-0 | Details |
| Bexicaserin | 2035818-24-5 | Details |
| Antiviral agent 27 | C24H34N2O | 2270947-36-7 | Details |
| ASN 07115873 | 626220-97-1 | Details |
| Anticancer agent 113 | C27H31ClN6O2 | 2495323-17-4 | Details |
| D1N52 | 2894770-48-8 | Details |
| AP-C4 | 682794-85-0 | Details |
| F1874-108 | C15H14N4O2S | 335223-43-3 | Details |
| Biotin-PEG3-amide-C2-CO-Halofuginone | 2758563-75-4 | Details |
| DHFR-IN-10 | 929484-47-9 | Details |
| CDK9-IN-29 | 2737262-24-5 | Details |
| Product Total： Product Page： | ||||
| 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||